Phase III, randomised, multicentre, controlled trial of maintenance biotherapy for metastatic renal cell cancer with Interleukin-2 and Interferon-alpha-2a. A study of the Italian Oncological Group for Clinical Research (GOIRC) / Passalacqua, R; Buzio, C; Porta, C; Labianca, R; Frassoldati, A; Buti, S; Pezzuolo, D; Vaglio, A; Tomasello, Gl; Dalla Chiesa, M; Camisa, R; Caminiti, C. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 15:(2004), pp. 98-98.

Phase III, randomised, multicentre, controlled trial of maintenance biotherapy for metastatic renal cell cancer with Interleukin-2 and Interferon-alpha-2a. A study of the Italian Oncological Group for Clinical Research (GOIRC)

Buti S;
2004-01-01

2004
Phase III, randomised, multicentre, controlled trial of maintenance biotherapy for metastatic renal cell cancer with Interleukin-2 and Interferon-alpha-2a. A study of the Italian Oncological Group for Clinical Research (GOIRC) / Passalacqua, R; Buzio, C; Porta, C; Labianca, R; Frassoldati, A; Buti, S; Pezzuolo, D; Vaglio, A; Tomasello, Gl; Dalla Chiesa, M; Camisa, R; Caminiti, C. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 15:(2004), pp. 98-98.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2906882
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact